In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

That Ozempic (or Wegovy, the name by which the weight-loss version of the drug semaglutide is marketed) should have proliferated in an industry that has always venerated thinness will hardly come as a ...

The global weight management market is poised for significant growth over the next decade, driven by increasing awareness of ...

Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

On Tuesday, U.S. Senator Mike Braun (R-Ind.) questioned Novo Nordisk CEO Lars Fruergaard Jørgensen at the Senate Health, ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

Sen. Bernie Sanders (I-Vt.) noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 a month in the U.S. but for ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

James Corden revealed that he gave Ozempic a try to help with weight loss, but soon found that his relationship with food had little to do with how hungry he was or wasn't.

James Corden is spilling his guts on Ozempic. The former late night host revealed that he gave Ozempic a try to help with ...